A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.

Seminars in oncology

Volumn 24, Issue 4 Suppl 12, 1997, Pages

  Birch, R ^a   Weaver, C H ^a   Hainsworth, J D ^a   Bobo, C ^a   Greco, F A ^a  

^a Response Oncology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SKULL IRRADIATION; SMALL CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY DOSAGE;

EID: 0031201317     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)